Breaking News, Collaborations & Alliances

Cycle Pharmaceuticals Selects LeMed as Exclusive U.S. Distribution & Services Partner for HARLIKU

LeMed will manage commercial and non-commercial dispensing for HARLIKU across the United States.

Author Image

By: Charlie Sternberg

Associate Editor

Cycle Pharmaceuticals has awarded LeMed Specialty Pharmacy the exclusive contract for specialty pharmacy distribution and services for HARLIKU (nitisinone) Tablets, the first and only FDA-approved treatment for use in alkaptonuria (AKU). LeMed will manage commercial and non-commercial dispensing for HARLIKU across the United States. “We’re excited to extend our partnership with LeMed Specialty Pharmacy, building on years of successful collaboration across rare diseases. Togethe...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters